Buy resTORbio Stock | TORC Stock Price & Latest News | Public
TORC

resTORbio

    Small Market Cap

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About TORC

    resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -1.85
    -3.7
    -5.55
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$1.12

    Actual EPS
    Q3 2020

    Stats

    Market Cap$217,05M
    Volume2,3k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$69.16
    1 Year Low$6.02
    Open$10.73
    High$11.38
    Low$10.73

    Buy any stock with any amount of money.

    Download the App
    Download the app